Oddway International

In the ever-evolving landscape of healthcare, breakthroughs in pharmaceuticals continue to redefine the possibilities for patients battling life-altering conditions. One such significant advancement is the   Viraday Tablet , a beacon of hope for individuals living with HIV/AIDS. Developed and meticulously formulated by the esteemed pharmaceutical company Cipla Limited, Viraday Tablet represents a paradigm shift in antiretroviral therapy. Understanding Viraday Tablet: A Triumph of Science Active Ingredients: Efavirenz IP, Emtricitabine IP, Tenofovir Disoproxil Fumarate IP AtViraday Tablet lies its powerful combination of active ingredients. Efavirenz IP, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is a potent force against HIV. It inhibits the reverse transcriptase enzyme, crucial for the virus’s replication, thereby hindering its progression in the body.  Emtricitabine  IP, a nucleoside analogue, further amplifies the antiviral action. By inhibiting reverse ...

In the relentless pursuit of combating HIV/AIDS, pharmaceutical advancements have played a pivotal role in enhancing the quality of life for millions. One such remarkable stride in the field of antiretroviral therapy is the Viraday Tablet . Manufactured by the renowned pharmaceutical company Cipla Limited, Viraday Tablet stands as a testament to scientific innovation and unwavering dedication to improving healthcare worldwide. Understanding Viraday: The Pill of Hope Viraday Tablet, bearing the distinguished brand name Viraday, is a potent combination of three active ingredients: Efavirenz IP, Emtricitabine IP, and Tenofovir Disoproxil Fumarate IP. These ingredients, meticulously blended and encapsulated into tablets, have revolutionized the management of HIV infections. Breaking Down the Formulation: A Trinity of Effectiveness Efavirenz IP (600 mg) : Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is a key component in Viraday. It works by hindering the activity of...